Showing results (1091-1100 of 4,565) with videos related to

Sort By:
Pageof 457
Advances in Therapy|September 8, 2026
Assessment of the Value of Nivolumab Plus Ipilimumab for Treating Microsatellite Instability-High/Mismatch Repair Deficiency Metastatic Colorectal Cancer: Indirect Treatment Comparison and Cost-Effectiveness AnalysisLytske J Bakker, Katharina Nickel, Zoe Cheah, et al.
Advances in Therapy|September 3, 2026
Long-Term Cost-Effectiveness of an Advanced Hybrid Closed-Loop Automated Insulin Delivery System Versus Multiple Daily Insulin Injections Plus Continuous Glucose Monitoring in Adults with Type 1 Diabetes in AustraliaSarah Glastras, Meaghan Read, Aslı Zeynep Ozdemir Saltik, et al.
Advances in Therapy|September 11, 2026
Characteristics of Medicare and Medicaid Patients Initiating Volara Respiratory Therapy: A Medical Claims StudyWendy M Qi, Suhui Evelyn Li, Jocelyn M Klabnik, et al.
Advances in Therapy|September 6, 2026
Real-World Longitudinal Treatment Outcomes for Patients with Metastatic Castration-Sensitive Prostate Cancer in JapanTaketo Kawai, Fumiko Kiyonaga, Satoshi Uno, et al.
Advances in Therapy|September 28, 2026
Perspectives on Living with Relapsed/Refractory Multiple Myeloma and Multidisciplinary Care from a Patient, Nurse Practitioner, Dietitian, and a Patient AdvocateBecky Bosley, Isabelle Wlodkowski, Donna Catamero, et al.
Advances in Therapy|October 11, 2026
Perinatal Outcomes of Pleuro-Amniotic Shunting in Isolated Pleural Effusions: Systematic Review and Meta-analysisEnzo Lofredo Amorim, Edward Araujo Júnior, Mucio Cevulla da Silva Lourenço, et al.
Advances in Therapy|October 9, 2026
Estimating Long-Term Organ Damage Risk in Patients with Congenital Thrombotic Thrombocytopenic Purpura Receiving Recombinant ADAMTS13 Prophylaxis: A Structured Expert Elicitation StudyAmie Padhiar, Colin Burke, Mathilde Puls, et al.
Advances in Therapy|October 14, 2026
Ibogaine for Substance Use DisordersAhmed I Anwar, Abdul-Rahman A Hegazi, M Farris Sawaya, et al.
Advances in Therapy|October 15, 2026
Safety, Efficacy, and Pharmacokinetics of Agalsidase Alfa in Treatment-Naive Chinese Patients with Fabry Disease: 52-Week Phase 3, Open-Label, Single-Arm StudyHong Ren, Jianhua Mao, Rong Wang, et al.
Advances in Therapy|October 12, 2026
Economic Evaluations of Hearing Interventions in Older Adults: A Systematic Review of Evidence and MethodsSmriti Raichand, Shan Jiang, Junling Weng, et al.
Pageof 457